This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
Accepts major insurance plans—including Medicare, Medicaid, WellCare, CareSource, and Amerigroup. Offers discounted self-pay rates and helps uninsured clients explore grant programs. Call us at (888) 858-1723 to explore affordable options and start your treatment journey today.
Just less than a mile walk from Levisia Fork River, the center offers outpatient support in a space that feels local and welcoming. Since 2014, it has delivered comprehensive support through medication-assisted treatment (MAT), using FDA-approved suboxone to ease withdrawal symptoms and curb cravings, alongside weekly group therapy. The facility operates Monday through Thursday and remains closed Friday to Sunday.
The center provides FDA-approved suboxone to manage withdrawal symptoms and reduce cravings, complemented by weekly group therapy sessions that explore treatment topics like anger management. Patients receive personalized and trauma-informed care from a supportive team including substance use counselors, recovery support specialists, and clinicians. Intake is quick and often virtual, connecting individuals to medical assessments, medication, and peer support to build lasting recovery and regain life goals.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
CARF stands for the Commission on Accreditation of Rehabilitation Facilities. It's an independent, non-profit organization that provides accreditation services for a variety of healthcare services. To be accredited means that the program meets their standards for quality, effectiveness, and person-centered care.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.
Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.